'They don't always agree with our governments, their teachers or their parents, but it is the conviction of their ideas, and their determination to share them with the world that, I believe, is one......
It was clear in Brunei at the 8th East Asia Summit that China doesn’t want the South China Sea issue to even dominate the discussion, reports Sheela Bhatt, who is part of the prime minister's......
If Ranbaxy had to survive, it would have to grow abroad, induct professionals and invest in research, notes Bhupesh Bhandari Ranbaxy tasted success for the first time in the 1960s with its......
Even as India's largest drug maker, Ranbaxy, is confident of launching its first 'new drug' by January 2012 to combat malaria in the country, the global euphoria the potential drug had generated in......
Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal......
Even as Indian pharmaceutical majors like Glenmark, Ranbaxy and Dr Reddys are hoping to come out with new drugs through in-house research and development (R&D), the World Health Organisation (WHO)......
Ranbaxy has completed the second phase of the clinical trial of a revolutionary anti-malarial drug that could enable it to be the nation's first pharmaceutical company to launch a New Chemical......